| Physical signs and atherosclerotic cardiovascular disease in familial hypercholesterolemia: the HELLAS-FH Registry LS Rallidis, CV Rizos, KA Papathanasiou, G Liamis, I Skoumas, A Garoufi, ... Journal of Cardiovascular Medicine 25 (5), 370-378, 2024 | | 2024 |
| Association of Alkaline Phosphatase with Cardiovascular Disease in Patients with Dyslipidemia: A 6-Year Retrospective Study PS Adamidis, M Florentin, E Liberopoulos, AD Koutsogianni, ... Journal of Cardiovascular Development and Disease 11 (2), 60, 2024 | | 2024 |
| Obesity and atherosclerotic cardiovascular disease in adults with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry F Barkas, CV Rizos, G Liamis, I Skoumas, A Garoufi, L Rallidis, G Kolovou, ... Journal of Clinical Lipidology, 2024 | | 2024 |
| Familial Hypercholesterolemia in the Elderly: An Analysis of Clinical Profile and Atherosclerotic Cardiovascular Disease Burden from the Hellas-FH Registry C Antza, CV Rizos, V Kotsis, G Liamis, I Skoumas, L Rallidis, A Garoufi, ... Biomedicines 12 (1), 231, 2024 | | 2024 |
| Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study KI Dharmayat, AJ Vallejo-Vaz, CAT Stevens, JM Brandts, ARM Lyons, ... The Lancet 403 (10421), 55-66, 2024 | 4 | 2024 |
| One year follow-up of cardiovascular profile and therapeutic management of children and adolescents with familial hyphercholesterolemia: Preliminary data from the Hellas-FH … C Rizos, G Liamis, A Garoufi, I Skoumas, L Rallidis, G Sfikas, G Kolovou, ... Atherosclerosis 379, S188-S189, 2023 | | 2023 |
| Prevalence of distal sensory peripheral neuropathy and albuminuria in individuals with prediabetes G Anastasiou, F Barkas, N Papanas, N Tentolouris, G Liamis, ... Atherosclerosis 379, S159-S160, 2023 | | 2023 |
| Hypolipidaemic treatment in patients with elevated lipoprotein (a) AD Koutsogianni, F Barkas, C Tellis, PS Adamidis, A Tselepis, G Liamis, ... Atherosclerosis 379, S47-S48, 2023 | | 2023 |
| Correlation of fatty index liver with incident diabetes risk in statin-treated patients: A 6-year retrospective study F Barkas, G Anastasiou, AD Koutsogianni, PS Adamidis, E Petkou, K Kyrili, ... Atherosclerosis 379, S33, 2023 | | 2023 |
| Overweight/obesity and prevalent atherosclerotic cardiovascular disease in patients with heterozygous familial hypercholesterolemia: An analysis from HELLAS-FH registry F Barkas, C Rizos, G Liamis, I Skoumas, A Garoufi, L Rallidis, G Kolovou, ... Atherosclerosis 379, S61, 2023 | | 2023 |
| Hypophosphatemia and cardiovascular disease: Data from a greek population study E Megapanou, M Florentin, G Anastasiou, G Liamis Atherosclerosis 379, S89, 2023 | | 2023 |
| Triglycerides and atherosclerotic cardiovascular disease in adult patients with familial hypercholesterolemia: Data from the Hellas-FH registry C Rizos, G Liamis, I Skoumas, A Garoufi, L Rallidis, G Kolovou, ... Atherosclerosis 379, S117, 2023 | | 2023 |
| The effect of statin monotherapy or add-on ezetimibe treatment on netosis ΙΝ dyslipidemic patients PS Adamidis, D Pantazi, F Barkas, I Moschonas, AD Koutsogianni, ... Atherosclerosis 379, S14-S15, 2023 | | 2023 |
| Lipids and RAS blockers plus CCB combinations. Alternations in prediabetic hypertensive patients, a randomized 12-week open-label comparative study A Liontos, D Biros, C Papagiannopoulos, C Veliani, A Papathanasiou, ... Atherosclerosis 379, S72-S73, 2023 | | 2023 |
| Distribution and variation of lipoprotein (a) in patients attending a lipid clinic in Greece F Barkas, AD Koutsogianni, G Anastasiou, PS Adamidis, K Kyrili, G Liamis, ... Atherosclerosis 379, S47, 2023 | 1 | 2023 |
| Metabolic syndrome and atherosclerotic cardiovascular disease in non-diabetic adult patients with familial hypercholesterolemia: Data from the Hellas-FH registry C Rizos, G Liamis, I Skoumas, A Garoufi, L Rallidis, G Kolovou, ... Atherosclerosis 379, S117, 2023 | | 2023 |
| BLOOD PRESSURE REDUCTION WITH 3 FIXED-SINGLE PILL COMBINATION TREATMENTS OF RAS-BLOCKERS PLUS CCB AMONG PREDIABETIC HYPERTENSIVE PATIENTS. A RANDOMIZED 12-WEEK OPEN-LABEL STUDY A Liontos, D Biros, C Papagiannopoulos, I Tsiakas, E Christaki, ... Journal of Hypertension 41 (Suppl 3), e123-e124, 2023 | | 2023 |
| Effects of Lipid-Modifying and Other Drugs on Lipoprotein (a) Levels—Potent Clinical Implications AD Koutsogianni, G Liamis, E Liberopoulos, PS Adamidis, M Florentin Pharmaceuticals 16 (5), 750, 2023 | 7 | 2023 |
| A step-by-step guide for the diagnosis and management of hyponatraemia in patients with stroke F Barkas, G Anastasiou, G Liamis, H Milionis Therapeutic Advances in Endocrinology and Metabolism 14, 20420188231163806, 2023 | 3 | 2023 |
| Association of Fatty Liver Index with Incident Diabetes Risk in Patients Initiating Statin–Therapy: A 6-Year Retrospective Study G Anastasiou, E Liberopoulos, E Petkou, AD Koutsogianni, PS Adamidis, ... Diagnostics 13 (3), 503, 2023 | 2 | 2023 |
